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Assessing risk for HIV infection among adolescent girls in South Africa: an
evaluation of the VOICE risk score (HPTN 068)
Abstract

INTRODUCTION: To maximize impact and minimize costs, antiretroviral pre-exposure prophylaxis
(PrEP) interventions should be offered to those at highest risk for HIV infection. The risk score derived from
the VOICE trial is one tool currently being utilized to determine eligibility in adolescent PrEP trials in subSaharan Africa. This study is aimed at evaluating the utility of the risk score in predicting HIV incidence
among a cohort of adolescent girls in rural South Africa.
METHODS: We utilized data from HIV Prevention Trials Network (HPTN) 068, a phase III randomized
controlled trial conducted in rural Mpumalanga province, South Africa. School-attending young women aged
13 to 20 years were enrolled into the trial from 2011 to 2012 and followed for up to three years. A risk score
based on individual-level risk factors measured at enrolment was calculated for HPTN 068 participants who
completed a one-year follow-up visit and were HIV seronegative at enrolment. Possible scores ranged from 0
to 10. A proportional hazards model was then used to determine if risk score at enrolment was predictive of
incident HIV infection at follow-up and an area under the curve analysis was used to examine the predictive
ability of the score.
RESULTS AND DISCUSSION: The risk score had limited variability in the HPTN 068 sample. Scores ≥5
identified 85% of incident infections from 94% of the sample, compared to the VOICE sample in which scores
≥5 identified 91% of incident infections from only 64% of participants. The risk score did not predict HIV
incidence after one year of follow-up (hazard ratio = 1.029; 95% confidence interval (CI): 0.704, 1.503, p =
.884) and showed poor predictive ability (area under the curve = 0.55; 95% CI: 0.44, 0.65). Certain individual
risk factors that comprise the risk score may be context specific or not relevant for adolescent populations.
Additional factors should be considered when assessing risk for the purposes of determining PrEP eligibility.
CONCLUSIONS: The VOICE risk score demonstrated low utility to predict HIV incidence in the HPTN
068 sample. Findings highlight the need for an age and developmentally appropriate tool for assessing risk for
HIV infection among adolescents. Use of the VOICE risk score for determining PrEP eligibility in younger
populations should be carefully considered.
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SHORT REPORT

Assessing risk for HIV infection among adolescent girls in South
Africa: an evaluation of the VOICE risk score (HPTN 068)
Danielle Giovenco1§ , Audrey Pettifor1 , Catherine MacPhail2,3, Kathleen Kahn3, Ryan Wagner3,
Estelle Piwowar-Manning4, Jing Wang5 and James P Hughes6
§
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Abstract
Introduction: To maximize impact and minimize costs, antiretroviral pre-exposure prophylaxis (PrEP) interventions should be
offered to those at highest risk for HIV infection. The risk score derived from the VOICE trial is one tool currently being utilized to determine eligibility in adolescent PrEP trials in sub-Saharan Africa. This study is aimed at evaluating the utility of the
risk score in predicting HIV incidence among a cohort of adolescent girls in rural South Africa.
Methods: We utilized data from HIV Prevention Trials Network (HPTN) 068, a phase III randomized controlled trial conducted in rural Mpumalanga province, South Africa. School-attending young women aged 13 to 20 years were enrolled into
the trial from 2011 to 2012 and followed for up to three years. A risk score based on individual-level risk factors measured
at enrolment was calculated for HPTN 068 participants who completed a one-year follow-up visit and were HIV seronegative
at enrolment. Possible scores ranged from 0 to 10. A proportional hazards model was then used to determine if risk score at
enrolment was predictive of incident HIV infection at follow-up and an area under the curve analysis was used to examine the
predictive ability of the score.
Results and Discussion: The risk score had limited variability in the HPTN 068 sample. Scores ≥5 identified 85% of incident
infections from 94% of the sample, compared to the VOICE sample in which scores ≥5 identified 91% of incident infections
from only 64% of participants. The risk score did not predict HIV incidence after one year of follow-up (hazard
ratio = 1.029; 95% confidence interval (CI): 0.704, 1.503, p = .884) and showed poor predictive ability (area under the
curve = 0.55; 95% CI: 0.44, 0.65). Certain individual risk factors that comprise the risk score may be context specific or not
relevant for adolescent populations. Additional factors should be considered when assessing risk for the purposes of determining PrEP eligibility.
Conclusions: The VOICE risk score demonstrated low utility to predict HIV incidence in the HPTN 068 sample. Findings highlight the need for an age and developmentally appropriate tool for assessing risk for HIV infection among adolescents. Use of
the VOICE risk score for determining PrEP eligibility in younger populations should be carefully considered.
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1 | INTRODUCTION
Biomedical HIV prevention technologies, such as antiretroviral
pre-exposure prophylaxis (PrEP), hold enormous potential to
substantially reduce HIV acquisition in high-risk populations
globally. To maximize impact and minimize costs, PrEP interventions should be offered to those at highest risk for HIV
infection. HIV risk assessment tools have been generated for
several key populations, including heterosexual HIV serodiscordant couples [1], men who have sex with men [2,3], and
pregnant and postpartum women [4].
In attempts to identify African women at greatest risk for
HIV infection, Balkus et al. [5] developed and validated a risk
assessment tool to predict one-year risk of HIV acquisition
among African women in generalized HIV epidemic settings,

where PrEP scale-up is especially warranted. The authors analysed data from three randomized placebo-controlled trials of
biomedical HIV prevention technologies, including the VOICE
trial, HIV Prevention Trials Network (HPTN) 035, and FEMPrEP. The VOICE trial assessed the safety and effectiveness of
daily oral tenofovir disoproxil fumarate (TDF), oral TDF/
emtricitabine (FTC), and 1% vaginal tenofovir gel as PrEP for
HIV prevention [6]. HPTN 035 and FEM-PrEP tested the
effectiveness of a microbicide gel and oral TDF/FTC respectively [7,8]. Baseline demographic, behavioural, clinical and
self-reported male partner characteristics from the VOICE
study were used to identify a discrete set of easy-to-measure
characteristics that were thought to be predictive of HIV
acquisition. These individual-level risk factors were assigned a
value and a total risk score for each participant was calculated
1
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by taking the sum of values for each risk factor, with possible
scores ranging from 0 to 11. The risk score was then externally validated by separately applying it to the HPTN 035 and
FEM-PrEP study populations. The VOICE trial, HPTN 035,
and FEM-PrEP all included women ≥18 years of age (Median
ages = 23-25 years).
Adolescents and young adults aged 15-24 years in subSaharan Africa account for over one-third all new infections,
with over twice as many new infections among young women
than young men [9]. Adolescents <18 years of age, however,
remain inadequately represented in biomedical HIV prevention research posing a significant challenge for integrating
strategies such as PrEP into effective combination prevention
packages [10]. To address this need, several open-label PrEP
demonstration studies aimed at understanding key barriers
and facilitators to PrEP acceptability, uptake, and adherence
among adolescents at highest risk for HIV infection are currently planned or ongoing in sub-Saharan Africa [11]. The risk
score derived from the VOICE trial is one tool currently being
utilized to determine PrEP eligibility in adolescent trials [12].
Therefore, this research was aimed at validating the risk score
for use in a population of adolescent girls in rural South
Africa.

2 | METHODS
Data from HPTN 068 was utilized for this analysis. HPTN
068 was a phase III randomized controlled trial conducted in
Mpumalanga province, South Africa within the Agincourt
Health and socio-Demographic Surveillance System site. This
region is a rural area characterized by high HIV prevalence,
poverty and migration for work [13]. The aim of the study was
to assess the impact of a cash transfer, conditioned on school
attendance, on HIV incidence. School-attending young women
aged 13 to 20 years, who were not married or pregnant, were
enrolled into the study between March 2011 and December
2012 and followed for up to three years. Written informed
consent from a primary caregiver (parent or legal guardian)
and written informed consent/assent from each young woman
was obtained prior to participation. More information on
HPTN 068 study methods are detailed elsewhere [14,15].
The risk score derived from the VOICE trial, which incorporates age, living with a primary partner, having a partner provide financial or material support, having partner who has
other partners, any alcohol use in the past three months, and
herpes simplex virus type 2 (HSV-2) serostatus, was calculated
at baseline for participants with complete data for individuallevel risk factors who were HIV seronegative. HPTN 068 participants were asked to provide information on their current
partner(s). Participants were asked if they were currently living with each partner (yes/no), if they were receiving financial
(“has [your partner] ever given you money?”) or material (“has
[your partner] ever given things, like groceries, clothes or airtime, that help you get by”) support from each partner (yes/
no), and if each partner had other sexual partners (yes/no/
don’t know). If HPTN 068 participants reported “yes” or “don’t
know” for least one partner, they were categorized as such
for each risk factor. HPTN 068 did not collect data on curable
sexually transmitted infections (STIs); therefore, the full risk
score was adapted to exclude this risk factor (range = 0-10).

See Appendix for the full risk score derived from the VOICE
trial.
Consistent with the VOICE risk score derivation and validation analyses, and when we hypothesized that the predictive
ability of baseline risk factors would be strongest, we examined the relationship between baseline risk score and HIV
incidence after one year of follow-up. One-year HIV incidence
was observed for participants with a follow-up visit occurring
between 6 and 18 months post-baseline. The number of incident infections was examined by risk score and a proportional
hazards model was used to determine if baseline risk score
was predictive of incident HIV infection. The area under the
receiver operating characteristic curve (AUC) was used to
assess the performance of the risk score in the HPTN 068
study population and the sensitivity and specificity at different
risk score cut-points were calculated.

3 | RESULTS AND DISCUSSION
In the HPTN 068 sample, 99% of participants had complete
baseline data for individual-level risk factors (N = 2503/
2533). Included in the analysis were 2178 participants with
a one-year follow-up visit who were HIV seronegative at
baseline. Participant demographic and behavioural characteristics are shown in Table 1. The median age of participants
was 15 years (interquartile range = 14-17 years). The majority of participants (89%) were under 18 years of age.
Approximately 31% of participants had a “boyfriend or main
partner,” 24% had at least one sex partner in their lifetime,
and 22% had at least one sex partner in the past three
months.
The distribution of HPTN 068 participants across individual
risk factors that comprise the risk score at baseline are presented in Table 2. All participants were under 25 years of

Table 1. Participant demographic and behavioural characteristics
Total (N = 2178)a
Age

15 (14-17)

School grade
Grade 8 (13-15 years)

567 (26.03)

Grade 9 (14-16 years)

606 (27.82)

Grade 10 (16-17 years)

600 (27.55)

Grade 11 (17-18 years)

405 (18.6)

Prior pregnancyb

169 (7.76)

Current boyfriend or main partnerc

680 (31.22)

Lifetime sexual partners
0
1

1636 (75.60)
284 (13.12)

≥2

244 (11.28)

Missing (refused to answer)

14

Sexually active (past three months)

467 (21.57)

Missing (refused to answer)
a

13
b

Data are median (interquartile range) or N (%); participants enrolled
in HPTN 068 could not be currently pregnant; cincludes non-sexual
partners.
2
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age. Approximately 3% reported that they were living with a
primary partner, 21% were receiving financial or material support from a partner, and 19% reported having a partner with
other partners. Furthermore, 9% of the sample had used
alcohol in the past three months and 4% were HSV-2
seropositive. Univariate analyses of individual risk factors and
HIV incidence revealed that having a partner provide financial
or material support was associated with increased risk for
HIV infection (p < .001). This finding is dissimilar to the
VOICE trial, where having a partner provide financial or
material support was found to be protective against HIV
infection.
There were 33 HIV seroconversions during 2455 personyears of follow-up (1.34% incidence over an average followup period of 1.13 years). HIV incidence by risk score is
shown in Figure 1. A majority (71%) of participants received
a risk score of 5 (range = 2-10). Scores ≥5 identified 85% of
incident infections from 94% of the sample. In the VOICE
sample, scores ≥5 identified 91% of incident infections from
only 64% of participants. Therefore, a larger proportion of
participants were categorized as being “at risk” (with a risk
score cut-point of ≥5) and, among these participants, fewer
incident infections were identified in the HPTN 068 cohort
compared with the VOICE cohort. To maximize impact and
minimize costs, biomedical HIV prevention technologies
should be offered to those at highest risk for HIV infection.
With a cut-point of ≥5, for example, 94% of the HPTN 068
sample would be eligible for PrEP.

Table 2. Key baseline risk factors in the HPTN 068 study
population
HPTN 068

Univariate

Individual risk

Risk

(N = 2178)

analysis

factors

score

N (%)

HR (95% CI)

2

2178 (100.00)

Age
<25 years

≥25 years
0
Living with primary partner

0 (0.00)

No

2

2103 (96.56)

Yes

0

75 (3.44)

–
1.00
0.43 (0.13, 1.41)
1.00

Partner provides financial/material support
No

1

1721 (79.02)

Yes

0

457 (20.98)

0.31 (0.16, 0.62)*
1.00

Primary partner has other partners
Yes/don’t know
No

2
0

407 (18.69)
1771 (81.31)

1.69 (0.82, 3.50)
1.00
1.36 (0.48, 3.88)

Alcohol use in past three months
Yes

1

192 (8.82)

No

0

1986 (91.18)

1.00

HSV-2 seropositive
Yes

2

77 (3.54)

No

0

2101 (96.46)

HR, hazard ratio; CI, confidence interval.
*p < .05.

2.82 (0.98, 8.10)
1.00

Risk score did not predict HIV incidence (hazard ratio
(HR) = 1.029, 95% confidence interval (CI): 0.704, 1.503,
p = 0.884). Furthermore, among a subset of 528 adolescents
included in the analysis who had at least one lifetime sexual
partner at baseline, there were 18 HIV seroconversions during 603 person-years of follow-up (2.99% incidence). The risk
score still did not predict HIV incidence (HR = 0.877, 95% CI:
0.635, 1.211, p = 0.424).
Among the 2,178 participants included in the analysis, the
AUC for the risk score was 0.55 (95% CI: 0.44, 0.65). In the
derivation and initial validation cohorts [5], all of which
included women 18 years of age or older, the risk score performed more accurately. The AUC for the risk score in the
HPTN 068 sample was lower than the AUC observed in the
VOICE study (AUC = 0.71, 95% CI: 0.68, 0.74) and an external validation in HPTN 035 (AUC = 0.70, 95% CI: 0.65, 0.75),
and similar to an external validation in FEM-PrEP
(AUC = 0.58, 95% CI: 0.51, 0.65). The predictive ability of the
risk score in the HPTN 068 cohort was also lower than a single-item question identifying sexually active adolescent girls
(AUC = 0.65, 95% CI: 0.57, 0.74).
An analysis of additional performance characteristics for
the full sample revealed that adequate sensitivity was only
maintained under very low specificity. A risk score cut-point
of ≥5 had a sensitivity and specificity of 85% and 6%
respectively (see Table 3), with 94% PrEP eligibility. With a
cut-point of >5, however, only 23% of the sample would be
eligible for PrEP, with a sensitivity of 39% and specificity of
78%. Given the large proportion of HPTN 068 participants
who received a risk score of exactly 5 (71%), there is no
clear cut-point for identifying adolescents at risk for HIV
infection using the VOICE risk score. In the VOICE derivation cohort, a risk score cut-point of ≥5 had a sensitivity of
91% and a specificity of 38%. Furthermore, the HPTN 035
external validation cohort, which did not include alcohol use
in their risk score (maximum score = 10), had a sensitivity
and specificity of 58% and 71% respectively, with a cutpoint of ≥5. Lastly, the FEM-PrEP validation cohort, which
excluded risk factors such as alcohol use, having a partner
provide financial or material support, and HSV-2 serostatus
(maximum score = 4), had a sensitivity and specificity of
83% and 31% respectively, with a cut-point of ≥2. While
the desired sensitivity and specificity would be highly dependent on the resource constraints and the availability of PrEP
in the setting in which it is being prescribed, there would
ideally be a less significant tradeoff.
Findings show that certain individual-level risk factors from
the VOICE risk score may not be relevant for adolescent populations. For example, the entire HPTN 068 study population
was under 25 years of age (median age at baseline = 15 years). Furthermore, the individual risk factors
derived from the VOICE study may not be relevant to the
adolescent developmental trajectory. No HPTN 068 participants were married (per inclusion criteria), less than one-third
had a primary partner, and less than one-quarter were sexually active. Therefore, questions related to cohabitation, partner support, and partner behaviour may not be appropriate.
Even when only sexually active adolescents were observed,
however, the risk score still did not predict HIV incidence.
The VOICE risk-score may also not be relevant for the
HPTN 068 context. HPTN 068 enrolled adolescent girls
3
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Risk score
Risk
Number of Total N
score
infections
(N = 2178)
2
2
14
3
0
2
4
3
118
5
15
1550
6
8
321
7
3
136
8
2
25
9
0
11
10
0
1
†
CI = Confidence Interval

Person-years
(PYS) of follow-up
15.50
2.26
133.41
1739.61
366.34
155.10
28.21
13.30
1.13

HIV incidence per 100
PYS (95% CI†)
12.91 (3.23, 51.61)
0.00
2.25 (0.73, 6.97)
0.86 (0.52, 1.43)
2.18 (1.09, 4.37)
1.93 (0.62, 6.00)
7.09 (1.77, 28.35)
0.00
0.00

Figure 1. One-year HIV incidence by risk score. CI’s calculated using the quadratic approximation to the Poisson log likelihood for the lograte parameter.

Table 3. Detailed sensitivity and specificity by risk score cut-point
Incident infections (n = 33)
Cut-point

Non-infections (n = 2145)

True positives

False negatives

False positives

≥2

33

0

2145

0

100.00

0.00

≥3
≥4

31
31

2
2

2133
2131

12
14

93.94
93.94

0.56
0.65

≥5

28

5

2016

129

84.85

6.01

≥6

13

20

481

1664

39.39

77.58

≥7

5

28

168

1977

15.15

92.17

≥8

2

31

35

2110

6.06

98.37

≥9

0

33

12

2133

0.00

99.44

≥10

0

33

1

2144

0.00

99.95

>10

0

33

0

2145

0.00

100.00

from a rural region in Mpumalanga province, an area characterized by high HIV prevalence, poverty and migration for
work. Adolescent girls and young women in this context

True negatives

Sensitivity, %

Specificity, %

may navigate partnerships differently than South African
populations more generally. While HPTN 068, the VOICE
study, and the validation cohorts all included women from
4
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South Africa, there may be variability in risk factors
between study sites.
Additional risk factors should be considered when assessing
risk for HIV infection in adolescent populations. For example,
sexual debut, having multiple sexual partners (both primary
and casual partner types), and inconsistent condom use should
be explored as potential risk factors. Furthermore, risk assessment tools for adolescents should consider context specific
factors in addition to age, gender, and developmentally appropriate factors. For example, research has demonstrated the
protective effect of schooling on HIV risk (and risk associated
with dropping out of school), especially among adolescent girls
in rural contexts [16-18]. Furthermore, research among adolescent girls and young women in this context has shown that
having older partners [19,20] and engaging transactional sex
[21,22] are predictive of HIV incidence. Findings from our univariate analysis also demonstrate that having a partner who
provides financial or material support is associated with
increased risk for HIV infection. In comparison to the VOICE
trial, where this factor was protective of HIV risk and suggested to be a proxy for relationship stability, having a partner
provide financial or material support may be an indicator of
higher risk transactional sex among younger populations.
Lastly, in addition to identifying those at greatest risk for
HIV infection, another challenge is identifying adolescents who
perceive themselves to be at risk and thus will be likely to
adhere to a biomedical prevention technology such as PrEP
[23,24]. By balancing interest in PrEP based on perceptions of
risk and risk for HIV infection itself, a cost-effective approach
to identifying adolescents who are most likely to benefit from
the intervention can be implemented.
There are several potential limitations to this research.
First, response bias is likely to occur for sensitive questions,
especially among adolescent participants. For example, HPTN
068 participants may be more likely to under-report sexual
activity and substance use compared to older participants in
the VOICE cohort. Second, this analysis utilized data from a
trial conducted from 2011 to 2014. While the data were collected several years prior to these analyses, HPTN 068
offered a large, longitudinal cohort of adolescent girls in rural
South Africa with minimal missing data and unmeasured confounding that we feel is still relevant to new and ongoing
PrEP implementation efforts. However, given the use of a secondary data source, there are likely differences in how individual risk factors were defined. Furthermore, HPTN 068 did not
collect data on curable STIs, a risk factor identified in the
VOICE analysis. Lastly, HPTN 068 enrolled young women who
were currently in school. Therefore, this population may be at
lower risk for engaging in certain risk behaviours compared to
young women who were not in school or who have had less
schooling, resulting in possible selection bias.

4 | CONCLUSIONS
We found that a risk score developed among adult women to
predict HIV incidence and that is being used to target PrEP
use in some settings was not helpful in identifying those at
highest risk in a population of adolescent girls in South Africa.
Findings highlight the need for an age and developmentally
appropriate tool for assessing risk for HIV infection among

adolescents in this context. Use of the VOICE risk score for
determining PrEP eligibility in younger populations should be
carefully considered.
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APPENDIX
Table A1. VOICE risk score
Baseline characteristics

Risk score

1. Age
<25 years
≥25 years
2. Married or living with husband or primary partner

2
0

No

2

Yes

0

3. Partner provides financial/material support
No

1

Yes

0

4. Primary sex partner has other partners
Yes
No

2
0

Don’t know

2

5. Alcohol use in past three months
Yes

1

No

0

6. HSV-2 seropositive
Yes
No
7. Any curable STIa
Yes
No
Maximum VOICE risk score

2
0
1
0
11

a

Chlamydia, gonorrhea, trichomoniasis, or syphilis.
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